# Regenerative Medicine Catalyst Grants

**Funder:** Novo Nordisk Foundation
**Budget:** Up to DKK 5M (standard) / Up to DKK 10M (collaborative); total pool DKK 100M
**Deadline:** 1 September 2026 (Two-phase process; Phase I concept note deadline not specified. Webinar on 4 August 2026. Grants awarded over 2026–2027.)
**Duration:** Up to 3 years
**Consortium:** No (optional for standard; required for collaborative projects — at least 1 international co-applicant from a different country)
**Application:** 2-stage: Phase I concept note → Phase II full application with external peer review
**Eligible countries:** DK, SE, NO, FI, IS, GL, FO
**Official call:** https://novonordiskfonden.dk/en/grant/regenerative-medicine-catalyst-grants-2026/
**Last verified:** 5 July 2026

## Eligibility & scope

Main applicant must be an established investigator at a university, hospital, or non-profit research institution in a Nordic country (Denmark, Sweden, Norway, Finland, Iceland, Greenland, Faroe Islands). Translational/applied focus on stem cell-based therapies across four themes: allogeneic cell therapy, analytical methods, biomaterials, and clinical development. Fundamental discovery, adult immune cell (CAR-T/NK), and gene therapy projects are out of scope. For-profit partners may collaborate but cannot receive direct funding.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/novo-nordisk-foundation-regenerative-medicine-catalyst-grants-2026-09) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.